Abstract:Objective To identify and develop the optimal active immunization induction method for NMDAR encephalitis in rodents. Background Encephalitis is a devastating neurologic disorder with high morbidity and mortality. Many cases are autoimmune. N-Methyl-D-aspartic acid receptor (NMDAR) encephalitis (NMDARE), characterized by antibodies against the NMDAR in the blood and spinal fluid of patients, is the most common form of autoimmune encephalitis (AE). A translational rodent model of NMDARE would allow for in-depth studies into AE pathophysiology, leading to advances in the diagnosis and treatment of this debilitating neuropsychiatric disorder. Design/Methods 7-week-old female C57BL/6J mice were injected subcutaneously with an emulsion of complete Freund's adjuvant, attenuated Mycobacterium tuberculosis (TB), and a 30 amino acid peptide flanking the NMDAR NR1 subunit N368/G369 residue targeted by antibodies in NMDARE patients. Three different induction methods were tested by varying the amount and injection method of pertussis toxin, subcutaneous injection sites, reimmunization, and amounts of TB. Mice were bled biweekly and sacrificed at 2, 4, 6, 8, and 14 weeks. Serum and CSF NMDAR antibody titer; mouse behavior; hippocampal NMDAR protein and cluster density; and brain immune cell entry and cytokine content were examined. Results Immunized mice had serum and CSF NMDAR antibodies. Mice exhibited behavioral changes, altered hippocampal NMDAR protein, brain immune cell entry, and elevated cytokines in their brains. Titers were higher and changes were sustained in reimmunized mice. Conclusions Active immunization against the portion of the NMDAR targeted in patients with NMDARE resulted in robust production of NMDAR antibodies in the blood and spinal fluid, changes in hippocampal NMDAR protein, elevations in brain immune cells and cytokines, and behavioral changes in mice. Reimmunization was needed to sustain the responses. Active immunization therefore holds potential as a translational model of NMDARE, allowing for the creation of a novel generation of diagnostics and therapeutics.

Antibody-secreting cells as a source of NR1-IgGs in N-methyl-D-aspartate receptor-antibody encephalitis

Anti-N-methyl-D-aspartate Receptor Encephalitis: a Prospective Study Focused on Cerebrospinal Fluid and Clinical Symptoms

Identification of Anti-Collapsin Response Mediator Protein 2 Antibodies in Patients with Encephalitis or Encephalomyelitis

Single‐cell RNA sequencing reveals diverse B cell phenotypes in patients with anti‐NMDAR encephalitis

Study of B Cell Repertoire in Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Single-cell analyses of CSF and PBMCs from anti-NMDAR encephalitis patients reveals distinct characteristics of T cell subpopulations

Activation and clonal expansion of CD8+T cells in patients with anti-NMDAR encephalitis revealed by single-cell RNA sequencing analysis

Anti-NMDAR antibodies, the blood–brain barrier, and anti-NMDAR encephalitis

Specific and Polyfunctional T Cell Response Against N-Methyl-D-aspartate Receptor in an Autoantibody-Mediated Encephalitis Model

Single-cell transcriptomics reveals cell type–specific immune regulation associated with anti-NMDA receptor encephalitis in humans

Clinical Relevance of Cerebrospinal Fluid Antibody Titers in Anti-N-Methyl-d-Aspartate Receptor Encephalitis

Clinicopathological Characteristics of Dysplastic Teratomous Neuroglia with Anti-N-methyl-d-aspartate Receptor Encephalitis.

Clinical Analysis in Patients with Anti-N-methyl-d-aspartate Receptor Encephalitis

Active Immunization Against NMDA NR1 Subunit as a Model of Autoimmune Encephalitis

Anti-NMDAR encephalitis with GFAPα IgG: a case report

Single‐nucleus RNA sequencing unveils critical regulators in various hippocampal neurons for anti‐N‐methyl‐D‐aspartate receptor encephalitis

Autoantibodies Detection in Anti-N-methyl-d-aspartate Receptor Encephalitis.

NMDA Receptor Autoantibodies in Autoimmune Encephalitis Cause a Subunit-Specific Nanoscale Redistribution of NMDA Receptors

Autoimmune receptor encephalitis in ApoE ‐/‐ mice induced by active immunization with NMDA1

Structural and functional mechanisms of anti-NMDAR autoimmune encephalitis

Cytokines/Chemokines: Potential Biomarkers for Non-paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis